These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 28062872)
21. The landscape of hepatobiliary adverse reactions across 53 herbal and dietary supplements reveals immune-mediated injury as a common cause of hepatitis. Zhu J; Chen M; Borlak J; Tong W Arch Toxicol; 2020 Jan; 94(1):273-293. PubMed ID: 31720699 [TBL] [Abstract][Full Text] [Related]
34. Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics. García-Cortés M; Robles-Díaz M; Ortega-Alonso A; Medina-Caliz I; Andrade RJ Int J Mol Sci; 2016 Apr; 17(4):537. PubMed ID: 27070596 [TBL] [Abstract][Full Text] [Related]
35. Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. Frenzel C; Teschke R Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128912 [TBL] [Abstract][Full Text] [Related]
36. Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States. Avigan MI; Mozersky RP; Seeff LB Int J Mol Sci; 2016 Mar; 17(3):331. PubMed ID: 26950122 [TBL] [Abstract][Full Text] [Related]
37. Herb-Induced Liver Injury: Phylogenetic Relationship, Structure-Toxicity Relationship, and Herb-Ingredient Network Analysis. He S; Zhang C; Zhou P; Zhang X; Ye T; Wang R; Sun G; Sun X Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349548 [TBL] [Abstract][Full Text] [Related]
38. Drug- and herb-induced liver injury: a case series from a single center. Dağ MS; Aydınlı M; Oztürk ZA; Türkbeyler IH; Koruk I; Savaş MC; Koruk M; Kadayıfçı A Turk J Gastroenterol; 2014 Feb; 25(1):41-5. PubMed ID: 24918129 [TBL] [Abstract][Full Text] [Related]
39. Severe liver injury due to herbal and dietary supplements and the role of liver transplantation. Grewal P; Ahmad J World J Gastroenterol; 2019 Dec; 25(46):6704-6712. PubMed ID: 31857773 [TBL] [Abstract][Full Text] [Related]
40. Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia. Teschke R; Schulze J Drug Saf; 2012 Dec; 35(12):1091-7. PubMed ID: 22897137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]